Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)
Hands-On With Cadillac CT6: The New Sedan Taking On BMW
28:51 - Cadillac has unveiled its new flagship sedan, the CT6. This is the car the Detroit automaker created to take on the likes of the BMW 5- and 6-Series, and the Mercedes-Benz E Class. It’s one of eight all-new vehicles the brand will launch by the end of the decade. (Source: Bloomberg)
  • China Fully Committed to Financial Reform: Konyn
  • All The Planets Have Aligned for Iran: Shanahan
  • China March Manufacturing PMI Tops Estimates